Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Summary

This study represents the second Phase 1 study with GSK376501 and the goal is to further evaluate its safety and tolerability. The way the human body processes GSK376501 will also be determined.

Timeline

Start

2007-06

Primary completion

2007-12

Completion

2007-12

Drugs

Indications